USAdvisors Wealth Management, LLC
- SEC CIK
- 0001735605
- Latest filing
- Jul 29, 2026
LCTX holding history
Lineage Cell Therapeutics, Inc. in every 13F filed by USAdvisors Wealth Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LCTX overviewAll 13F holders of LCTXFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −10,869−100.0% | Sold out | Holders |
| Q3 2023 | 10,869 | $12.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 10,869 | $15.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 10,869 | $16.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 10,869 | $13.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 10,869 | $12.0K | <0.1% | +10,869 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −10,869−100.0% | Sold out | Holders |
| Q1 2022 | 10,869 | $17.0K | <0.1% | +10,869 | New | Holders |